As of 2026-10-24, the EV/EBITDA ratio of Aerie Pharmaceuticals Inc (AERI) is -58.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Aerie's latest enterprise value is 1,012.11 mil USD. Aerie's TTM EBITDA according to its financial statements is -17.25 mil USD. Dividing these 2 quantities gives us the above Aerie EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.2x - 19.9x | 18.9x |
| Forward P/E multiples | 15.6x - 18.1x | 17.5x |
| Fair Price | (10.67) - (11.56) | (11.58) |
| Upside | -170.0% - -175.8% | -176.0% |
| Date | EV/EBITDA |